| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0310-6105-90 | 0310-6105 | HUMAN PRESCRIPTION DRUG | ONGLYZA | SAXAGLIPTIN | TABLET, FILM COATED | ORAL | 20141219 | 20260331 | NDA | NDA022350 | AstraZeneca Pharmaceuticals LP | SAXAGLIPTIN HYDROCHLORIDE | 5 mg/1 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6105-90) |
| 0310-6105-30 | 0310-6105 | HUMAN PRESCRIPTION DRUG | ONGLYZA | SAXAGLIPTIN | TABLET, FILM COATED | ORAL | 20141218 | 20260331 | NDA | NDA022350 | AstraZeneca Pharmaceuticals LP | SAXAGLIPTIN HYDROCHLORIDE | 5 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6105-30) |